| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 2 | |
| #2 | China | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | United States | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Australia | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Acyclic or carbocyclic compounds | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Rioux Patrice R | 6 |
| #2 | Barski Piotr | 5 |
| #3 | Witt Dariusz | 5 |
| #4 | Stanton Vincent P Jr | 5 |
| #5 | Rioux Patrice P | 4 |
| #6 | Stanton Jr Vincent P | 3 |
| #7 | Rioux Patrice | 2 |
| #8 | Stanton Vincent | 2 |
| #9 | Stanton Vincent P | 2 |
| #10 | Patrice R Rioux | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN111683684A | Methods for treating cysteamine-sensitive disorders | |
| KR20180129826A | Compositions for controlled release of cysteamine and systemic treatment of cysteamine-sensitive disorders |